Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Axsome Therapeutics, Inc.(AXSM) | 1,468,983 | 815,176 | -653,807 | $124.29M | $95.07M | 14.75% | -$29.22M |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $92.80M | $76.54M | 11.87% | -$16.27M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $93.54M | $64.83M | 10.06% | -$28.71M |
| Enliven Therapeutics Inc | 3,202,798 | 3,202,798 | 0 | $72.06M | $63.03M | 9.78% | -$9.03M |
| Nuvalent Inc | 1,317,664 | 727,563 | -590,101 | $103.15M | $51.60M | 8.00% | -$51.55M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,700,691 | 2,700,691 | 0 | $58.88M | $48.99M | 7.60% | -$9.88M |
| Viridian Therapeutics, Inc.(VRDN) | 3,445,813 | 3,445,813 | 0 | $66.06M | $46.45M | 7.21% | -$19.61M |
| Scholar Rock Holding Corporation(SRRK) | 1,962,953 | 1,374,031 | -588,922 | $84.84M | $44.18M | 6.85% | -$40.66M |
| Cogent Biosciences, Inc.(COGT) | 6,225,641 | 6,225,641 | 0 | $48.56M | $37.29M | 5.79% | -$11.27M |
| Oruka Therapeutics, Inc.(ORKA) | 3,371,922 | 3,371,922 | 0 | $65.38M | $34.60M | 5.37% | -$30.79M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,194,341 | 1,102,248 | -1,092,093 | $43.40M | $24.48M | 3.80% | -$18.92M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $31.77M | $18.98M | 2.94% | -$12.79M |
| Zenas BioPharma, Inc.(ZBIO) | 1,892,806 | 1,892,806 | 0 | $15.50M | $14.95M | 2.32% | -$548.9K |
| Inhibikase Therapeutics, Inc.(IKT) | 6,125,000 | 6,125,000 | 0 | $19.91M | $13.41M | 2.08% | -$6.49M |
| Bicara Therapeutics Inc | 1,284,169 | 784,170 | -499,999 | $22.37M | $10.22M | 1.59% | -$12.15M |
| Anaptysbio Inc | 1,816,466 | 0 | -1,816,466 | $24.05M | $0 | — | -$24.05M |
| Day One Biopharmaceuticals Inc COM | 3,103,448 | 0 | -3,103,448 | $39.32M | $0 | — | -$39.32M |